Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2020 Feb;22(2):231-233.
doi: 10.1111/jch.13817. Epub 2020 Jan 31.

Renal resistive index as a novel biomarker for cardiovascular and kidney risk reduction in type II diabetes

Affiliations
Comment

Renal resistive index as a novel biomarker for cardiovascular and kidney risk reduction in type II diabetes

Annayya R Aroor et al. J Clin Hypertens (Greenwich). 2020 Feb.
No abstract available

PubMed Disclaimer

Conflict of interest statement

None.

Figures

Figure 1
Figure 1
Renal resistive index as a novel biomarker for cardiovascular and kidney risk reduction in type II diabetes

Comment on

References

    1. Aroor AR, Jia G, Sowers JR. Cellular mechanisms underlying obesity‐induced arterial stiffness. Am J Physiol Regul Integr Comp Physiol. 2018;314:R387‐R398. - PMC - PubMed
    1. Agirbasli M, Tanrikulu AM, Berenson GS. Metabolic syndrome: bridging the gap from childhood to adulthood. Cardiovasc Ther. 2016;34:30‐36. - PubMed
    1. Whaley‐Connell A, Sowers JR. Basic science: pathophysiology: the cardiorenal metabolic syndrome. J Am Soc Hypertens. 2014;8(8):604‐606. - PMC - PubMed
    1. Whaley‐Connell A, Sowers JR. Insulin resistance in kidney disease: is there a distinct role separate from that of diabetes or obesity? Cardiorenal Med. 2017;8:41‐49. - PMC - PubMed
    1. Cardoso CR, Salles GF. Aortic stiffness as a surrogate endpoint to micro‐ and macrovascular complications in patients with type 2 diabetes. Int J Mol Sci. 2016;17:E2044. - PMC - PubMed

Publication types